NEW YORK (GenomeWeb News) – Rosetta Genomics said today that institutional investors have agreed to around $5.1 million in securities through a direct share offering.

The molecular diagnostics developer plans to use the expected $4.5 million in proceeds from the offering for general corporate purposes.

Rosetta said it has agreed to sell an aggregate of 2.5 million of ordinary shares and warrants to purchase up to about 1.3 million more ordinary shares.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.